mizolastine has been researched along with Hives in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W | 1 |
| Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zeng, W; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W | 1 |
| Dubertret, L; Leynadier, F; Murrieta-Aguttes, M; Pecquet, C | 1 |
| Wang, RQ; Zhang, HY | 1 |
| Blondin, P; Brostoff, J; Dunmore, C; Fitzharris, P; Theron, M | 1 |
| Dubertret, L; Murrieta Aguttes, M; Tonet, J | 1 |
| Brockow, K; Engst, R; Ollert, M; Ring, J | 1 |
| Giannetti, A; Leynadier, F; Lorette, G; Murrieta-Aguttes, M; Pereira, RS | 1 |
| Deschamps, C; Dubruc, C; Mentre, F; Rosenzweig, P | 1 |
| Kontou-Fili, K | 1 |
| Aberer, W; Kränke, B | 1 |
| DeVos, C; Grant, JA; Moulaert, B; Riethuisen, JM | 1 |
| Frossard, N; Mélac, M; Pauli, G; Purohit, A | 1 |
9 trial(s) available for mizolastine and Hives
| Article | Year |
|---|---|
Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
Topics: Adult; Asian People; Benzimidazoles; China; Female; Genotyping Techniques; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Loratadine; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptors, IgE; Terfenadine; Urticaria; Young Adult | 2015 |
Mizolastine in primary acquired cold urticaria.
Topics: Adolescent; Adult; Benzimidazoles; Cold Temperature; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Urticaria | 2003 |
[Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Area Under Curve; Benzimidazoles; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Rhinitis, Allergic, Perennial; Skin Tests; Time Factors; Urticaria | 2004 |
Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Topics: Adult; Benzimidazoles; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Urticaria | 1996 |
Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Topics: Adult; Analysis of Variance; Appendicitis; Benzimidazoles; Chronic Disease; Double-Blind Method; Electrocardiography; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Patient Dropouts; Pruritus; Severity of Illness Index; Treatment Outcome; Urticaria; Vasculitis | 1999 |
One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.
Topics: Adult; Benzimidazoles; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Male; Urticaria | 2000 |
Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Topics: Administration, Oral; Adult; Benzimidazoles; Body Fluid Compartments; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Male; Models, Biological; Placebos; Predictive Value of Tests; Skin Tests; Urticaria | 2000 |
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Topics: Adult; Benzimidazoles; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Piperidines; Terfenadine; Treatment Outcome; Urticaria | 2002 |
Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
Topics: Adolescent; Adult; Benzimidazoles; Cetirizine; Cross-Over Studies; Dermatitis, Allergic Contact; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Male; Middle Aged; Skin Tests; Urticaria | 2002 |
4 other study(ies) available for mizolastine and Hives
| Article | Year |
|---|---|
Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Asian People; Benzimidazoles; Case-Control Studies; China; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Anaphylatoxin C5a; Risk Factors; Treatment Outcome; Urticaria; Young Adult | 2014 |
Antihistamines in urticaria.
Topics: Benzimidazoles; Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Urticaria | 1999 |
Clinical advantages of dual activity in urticaria.
Topics: Acute Disease; Anti-Allergic Agents; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Cold Temperature; Histamine; Histamine H1 Antagonists; Humans; Leukotrienes; Lipoxygenase Inhibitors; Urticaria | 2000 |
One-year treatment of chronic urticaria with mizolastine: efficacy and safety. J Eur Acad Dermatol Venereol 2000; 14: 83-90.
Topics: Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; Time Factors; Urticaria | 2001 |